Uses: indicated for the treatment of metastatic colorectal cancer to include information about KRAS mutations.
Vial
14817 EGP
Uses: indicated for the treatment of metastatic colorectal cancer to include information about KRAS mutations.
Note: All the provided information about this drug does not substitute for consulting a doctor.